Transce3nd’s Arcosa ACA Stock Holding History

Transce3nd’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-142	Closed	-$13.7K	–	1187
2024 Q4	$13.7K	Buy	+142	New	+$14.3K	﹤0.01%	659

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Transce3nd's ACA Position: Q1 2025 in Review

Transce3nd sold out of Arcosa (ACA) in Q1 2025, closing a stake of 142 shares — an estimated $13.7K sold.

Transce3nd first reported a position in ACA in Q4 2024 and held it in 1 quarter. The position peaked at $13.7K in Q4 2024. 314 funds tracked by Wall St. Rank hold ACA as of Q1 2025.

Transce3nd reported no remaining Arcosa position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 142 Arcosa shares in Q1 2025, an estimated $13.7K.
Transce3nd first reported a position in Arcosa in Q4 2024 and held it in 1 quarter.
Transce3nd's Arcosa position peaked at $13.7K in Q4 2024.
314 funds tracked by Wall St. Rank held Arcosa as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.